Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Eur J Med Res ; 27(1): 2, 2022 Jan 06.
Article in English | MEDLINE | ID: mdl-34991710

ABSTRACT

BACKGROUND: Malaria is still major problem in developing countries, such as Pakistan. Besides fever, body ache and vomiting it can present with acute kidney injury, proteinuria, hematuria and cerebral manifestations which are more common with falciparum malaria. Neurological manifestations are rare presentation of malaria and should be consider in patients who are admitting with features of neuropathy and stroke. CASE PRESENTATION: We describe an unusual case of falciparum malaria, complicated by acute kidney injury who developed Polyneuropathy and intra-arterial thrombosis in middle cerebral artery territory. Our patient recovered his renal functions during admission and recovered his power and sensation in his limbs as well after 1 month. CONCLUSION: Malaria cause neurological manifestations including axonal and sensory neuropathy, cerebral venous and arterial thrombosis, PMNS, cerebellar signs and symptoms, psychosis, etc. With prompt diagnosis and early treatment they can be cure and regain their motor and sensory functions to normal level.


Subject(s)
Acute Kidney Injury/etiology , Malaria, Falciparum/complications , Middle Cerebral Artery , Polyneuropathies/etiology , Thrombotic Stroke/etiology , Adolescent , Humans , Magnetic Resonance Angiography , Male , Thrombotic Stroke/diagnosis
2.
J Stroke Cerebrovasc Dis ; 30(10): 106005, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34332228

ABSTRACT

OBJECTIVES: This study assessed the temporal trends in the incidence of ischemic stroke among patients hospitalized with takotsubo cardiomyopathy (TCM) stratified by the subtypes of ischemic stroke (cardioembolic versus thrombotic). Predictors of each stroke subtype, the association with atrial fibrillation (AF), the occurrence of ventricular fibrillation/ventricular tachycardia (VF/VT), cardiogenic shock (CS), in-hospital mortality, length of stay (LOS), and total healthcare cost were also assessed. BACKGROUND: Ischemic stroke in TCM is thought to be primarily cardioembolic from left ventricular mural thromboembolism. Limited data are available on the incidence of thrombotic ischemic stroke in TCM. MATERIALS AND METHODS: We identified 27,970 patients hospitalized with the primary diagnosis of TCM from the 2008 to 2017 National Inpatient Sample, of which 751 (3%) developed ischemic stroke. Of those with ischemic stroke, 571 (76%) had thrombotic stroke while 180 (24%) had cardioembolic stroke. Cochrane armitage test was used to assess the incidence of thrombotic and cardioembolic strokes and multivariate regression was used to identify risk factors associated with each stroke subtype. We compared the incidence of AF, VF/VT, CS, LOS, in-hospital mortality and total cost between hospitalized patients with TCM alone to those with cardioembolic and thrombotic strokes. RESULTS: From 2008 - 2017, the incidence of thrombotic stroke (4.7%-9.5% (p< 0.0001) increased while it was unchanged for cardioembolic stroke (0.5%-0.7% P=0.5). In the multivariate regression, peripheral artery disease, prior history of stroke, and hyperlipidemia were significantly associated with thrombotic stroke, while CS, AF, and Asian race (compared to White race) were associated with cardioembolic stroke. Both cardioembolic and thrombotic strokes were associated with higher odds of IHM, AF, CS, longer LOS and increased cost. Trends in in-hospital mortality and the utilization of thrombolysis, cerebral angiography, and mechanical thrombectomy among patients with TCM and ischemic stroke were unchanged from 2008 to 2017. CONCLUSION: Among patients with TCM and ischemic stroke, thrombotic stroke was more common compared to cardioembolic stroke. Ischemic stroke was associated with poorer outcomes, including higher in-hospital mortality and increased healthcare resource utilization in TCM.


Subject(s)
Embolic Stroke/epidemiology , Hospitalization/trends , Takotsubo Cardiomyopathy/epidemiology , Thrombotic Stroke/epidemiology , Aged , Aged, 80 and over , Cerebral Angiography/trends , Databases, Factual , Embolic Stroke/diagnosis , Embolic Stroke/mortality , Embolic Stroke/therapy , Female , Health Care Costs/trends , Hospital Mortality/trends , Humans , Incidence , Inpatients , Length of Stay/trends , Male , Middle Aged , Predictive Value of Tests , Risk Assessment , Risk Factors , Takotsubo Cardiomyopathy/diagnosis , Takotsubo Cardiomyopathy/mortality , Takotsubo Cardiomyopathy/therapy , Thrombectomy/economics , Thrombectomy/mortality , Thrombectomy/trends , Thrombotic Stroke/diagnosis , Thrombotic Stroke/mortality , Thrombotic Stroke/therapy , Time Factors , Treatment Outcome , United States/epidemiology
3.
Medicine (Baltimore) ; 100(18): e25779, 2021 May 07.
Article in English | MEDLINE | ID: mdl-33950971

ABSTRACT

RATIONALE: Systemic lupus erythematosus (SLE) is an important cause of stroke, more than a half the cases present as acute ischemic stroke. Thrombolysis is an effective choice in most cases, but for large vessel occlusion, mechanical thrombectomy is more effective. Here we reported a case of SLE-related stroke with left middle cerebral artery (MCA) occlusion, who was successfully treated by MT and tirofiban. PATIENT CONCERN: A 38-year-old female suffered from right hemiplegia and aphasia for 8 hours. She was diagnosed with SLE 20 years ago, and neuropsychiatric SLE was considered 8 months before this onset. One month ago, glucocorticoids were discontinued by herself because of deterioration of bilateral femoral head osteonecrosis. DIAGNOSIS: Left MCA occlusion was confirmed by computed tomography perfusion. INTERVENTION: Immediate mechanical thrombectomy was performed and tirofiban was given to prevent re-occlusion of left MCA. Twenty fourhours later oral antiplatelet was given after intracranial hemorrhage was ruled out. OUTCOMES: Her neurological symptom improved several days later, and she was transferred to further rehabilitation. At 4 months follow-up she can live independently with mild hypophrasia. There was no further events of ischemic stroke in 1-year follow-up. LESSONS: Mechanical thrombectomy is a highly effective and indispensable treatment for SLE related large vessel occlusion. In addition, tirofiban may reduce vessel reocclusion in special cases such as SLE and artery stenosis.


Subject(s)
Infarction, Middle Cerebral Artery/therapy , Lupus Erythematosus, Systemic/complications , Thrombectomy/methods , Thrombotic Stroke/therapy , Tirofiban/administration & dosage , Adult , Female , Humans , Infarction, Middle Cerebral Artery/diagnosis , Infarction, Middle Cerebral Artery/immunology , Lupus Erythematosus, Systemic/immunology , Middle Cerebral Artery/diagnostic imaging , Middle Cerebral Artery/surgery , Perfusion Imaging , Thrombotic Stroke/diagnosis , Thrombotic Stroke/immunology , Tomography, X-Ray Computed/methods , Treatment Outcome
4.
Postgrad Med ; 133(2): 154-159, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33522353

ABSTRACT

OBJECTIVES: Alcohol consumption is a risk factor for stroke. However, there are no available data on the effect of alcohol consumption on the long-term outcome of ischemic stroke in China. Therefore, this study aimed to explore the association of alcohol consumption with the prognosis of ischemic stroke by subtype in different follow-up periods after stroke. METHODS: This 12-month follow-up study recruited 3830 acute ischemic stroke patients from Tianjin, China, between 2016 and 2018. Patients were categorized into two groups according to their consumption of alcohol. Differences in mortality, recurrence, and dependency rates at 3 and 12 months after stroke were compared between both groups. RESULTS: The mortality, recurrence, and dependency rates at 12 months after stroke were significantly higher in patients who previously consumed alcohol than in those without previous alcohol consumption (all P < 0.005). A similar trend was observed for mortality rate at 3 months after stroke (P < 0.001). The risk of death at 3 months after an atherothrombotic stroke decreased by 63.4% (relative risk [RR], 0.366; 95% confidence interval [CI], 0.144-0.935) among patients who previously consumed alcohol compared with those who never consumed alcohol. Moreover, for patients with small artery disease classified according to the Trial of ORG 10,172 in Acute Stroke Treatment (TOAST), the recurrence and dependency rates at 12 months after stroke decreased by 49.2% (RR, 0.508; 95% CI, 0.259-0.996) and 49.5% (RR, 0.505; 95% CI, 0.258-0.990), respectively, among patients who consumed alcohol. CONCLUSIONS: Previous alcohol consumption decreased the risk of death at 3 months after stroke among patients with atherothrombotic stroke according to the TOAST classification. Furthermore, for patients with small artery disease (according to TOAST classification), alcohol consumption significantly decreased the risk of recurrence and dependency at 12 months after stroke. This study highlights an urgent need to quantify the association of alcohol consumption with outcomes after stroke in China to improve stroke prognosis.


Subject(s)
Alcohol Drinking , Ischemic Stroke , Preventive Health Services/methods , Risk Assessment/methods , Thrombotic Stroke , Alcohol Drinking/epidemiology , Alcohol Drinking/physiopathology , China/epidemiology , Female , Heart Disease Risk Factors , Hospitalization/statistics & numerical data , Humans , Ischemic Stroke/epidemiology , Ischemic Stroke/physiopathology , Ischemic Stroke/psychology , Ischemic Stroke/therapy , Male , Medical History Taking/methods , Medical History Taking/statistics & numerical data , Middle Aged , Mortality , Prognosis , Recurrence , Thrombotic Stroke/diagnosis , Thrombotic Stroke/epidemiology
5.
Rev. invest. clín ; 73(1): 23-30, Jan.-Feb. 2021. tab, graf
Article in English | LILACS | ID: biblio-1289741

ABSTRACT

ABSTRACT Background: There is little information about the early clinical features of cardioembolic stroke before complementary examinations. Objective: The aim of this study was to identify risk factors, clinical features, and early outcomes of cardioembolic stroke. Methods: Retrospective study based on prospectively collected data available from a university medical center hospital-based stroke registry. Consecutive patients diagnosed with cardioembolic infarction were selected and compared to those diagnosed with an atherothrombotic stroke. Predictors of cardioembolic infarction were assessed by multivariate analysis. Results: From a cohort of 4597 consecutive patients, we studied 956 patients diagnosed with cardioembolic infarction (80 years [standard deviation (SD) 9.14]; 63% women) and 945 with atherothrombotic infarction (77.01 years [SD 9.75]; 49.8% women). The univariate comparative analysis reported that advanced age (≥ 85 years), female gender, atrial fibrillation (AF), ischemic heart disease, and congestive heart failure were significantly more frequent in the cardioembolic group, whereas hypertension, diabetes, peripheral vascular disease, heavy smoking, hyperlipidemia, and previous transient ischemic attack were significant in the atherothrombotic group. In the logistic regression model, AF (odds ratio [OR] 15.75, 95% confidence interval [CI]: 12.14-20.42), ischemic heart disease (OR 3.12, 95% CI: 2.16-4.5), female gender (OR 1.56, 95% CI: 1.22-2.00), and sudden-onset (OR 1.97, 95% CI: 1.54-2.51), were independent significant predictors of cardioembolic stroke. Conclusions: Potential cardioembolic stroke requires a comprehensive evaluation, since early classification and identification through predictors would improve effective management. (REV INVEST CLIN. 2021;73(1):23-30)


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Thrombotic Stroke/diagnosis , Embolic Stroke/diagnosis , Retrospective Studies , Risk Factors
6.
Rev Invest Clin ; 73(1): 023-030, 2020 05 07.
Article in English | MEDLINE | ID: mdl-33053576

ABSTRACT

BACKGROUND: There is little information about the early clinical features of cardioembolic stroke before complementary examinations. OBJECTIVE: The aim of this study was to identify risk factors, clinical features, and early outcomes of cardioembolic stroke. METHODS: Retrospective study based on prospectively collected data available from a university medical center hospitalbased stroke registry. Consecutive patients diagnosed with cardioembolic infarction were selected and compared to those diagnosed with an atherothrombotic stroke. Predictors of cardioembolic infarction were assessed by multivariate analysis. RESULTS: From a cohort of 4597 consecutive patients, we studied 956 patients diagnosed with cardioembolic infarction (80 years [standard deviation (SD) 9.14]; 63% women) and 945 with atherothrombotic infarction (77.01 years [SD 9.75]; 49.8% women). The univariate comparative analysis reported that advanced age (≥ 85 years), female gender, atrial fibrillation (AF), ischemic heart disease, and congestive heart failure were significantly more frequent in the cardioembolic group, whereas hypertension, diabetes, peripheral vascular disease, heavy smoking, hyperlipidemia, and previous transient ischemic attack were significant in the atherothrombotic group. In the logistic regression model, AF (odds ratio [OR] 15.75, 95% confidence interval [CI]: 12.14-20.42), ischemic heart disease (OR 3.12, 95% CI: 2.16-4.5), female gender (OR 1.56, 95% CI: 1.22-2.00), and sudden-onset (OR 1.97, 95% CI: 1.54-2.51), were independent significant predictors of cardioembolic stroke. CONCLUSIONS: Potential cardioembolic stroke requires a comprehensive evaluation, since early classification and identification through predictors would improve effective management.


Subject(s)
Embolic Stroke/diagnosis , Thrombotic Stroke/diagnosis , Aged , Aged, 80 and over , Female , Humans , Male , Retrospective Studies , Risk Factors
7.
Theranostics ; 10(17): 7480-7491, 2020.
Article in English | MEDLINE | ID: mdl-32685000

ABSTRACT

In the field of ischemic cerebral injury, precise characterization of neurovascular hemodynamic is required to select candidates for reperfusion treatments. It is thus admitted that advanced imaging-based approaches would be able to better diagnose and prognose those patients and would contribute to better clinical care. Current imaging modalities like MRI allow a precise diagnostic of cerebral injury but suffer from limited availability and transportability. The recently developed ultrafast ultrasound could be a powerful tool to perform emergency imaging and long term follow-up of cerebral perfusion, which could, in combination with MRI, improve imaging solutions for neuroradiologists. Methods: In this study, in a model of in situ thromboembolic stroke in mice, we compared a control group of non-treated mice (N=10) with a group receiving the gold standard pharmacological stroke therapy (N=9). We combined the established tool of magnetic resonance imaging (7T MRI) with two innovative ultrafast ultrasound methods, ultrafast Doppler and Ultrasound Localization Microscopy, to image the cerebral blood volumes at early and late times after stroke onset and compare with the formation of ischemic lesions.Results: Our study shows that ultrafast ultrasound can be used through the mouse skull to monitor cerebral perfusion during ischemic stroke. In our data, the monitoring of the reperfusion following thrombolytic within the first 2 h post stroke onset matches ischemic lesions measured 24 h. Moreover, similar results can be made with Ultrasound Localization Microscopy which could make it applicable to human patients in the future. Conclusion: We thus provide the proof of concept that in a mouse model of thromboembolic stroke with an intact skull, early ultrafast ultrasound can be indicative of responses to treatment and cerebral tissue fates following stroke. It brings new tools to study ischemic stroke in preclinical models and is the first step prior translation to the clinical settings.


Subject(s)
Cerebrovascular Circulation , Intravital Microscopy/methods , Middle Cerebral Artery/diagnostic imaging , Thrombotic Stroke/diagnosis , Ultrasonography, Doppler/methods , Animals , Brain/blood supply , Brain/diagnostic imaging , Disease Models, Animal , Fibrinolytic Agents/administration & dosage , Humans , Intravital Microscopy/instrumentation , Magnetic Resonance Imaging , Male , Mice , Proof of Concept Study , Recombinant Proteins/administration & dosage , Recombinant Proteins/toxicity , Thrombolytic Therapy , Thrombotic Stroke/chemically induced , Thrombotic Stroke/drug therapy , Time Factors , Tissue Plasminogen Activator/administration & dosage , Tissue Plasminogen Activator/toxicity , Ultrasonography, Doppler/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...